These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 22364872)
1. New insights into the regulation of Na+,K+-ATPase by ouabain. Silva E; Soares-da-Silva P Int Rev Cell Mol Biol; 2012; 294():99-132. PubMed ID: 22364872 [TBL] [Abstract][Full Text] [Related]
2. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation. Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827 [TBL] [Abstract][Full Text] [Related]
3. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation. Cornelius F; Mahmmoud YA Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013 [TBL] [Abstract][Full Text] [Related]
4. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells. Gentile DA; Skoner DP Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446 [TBL] [Abstract][Full Text] [Related]
6. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism. Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978 [TBL] [Abstract][Full Text] [Related]
7. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo. Golden WC; Martin LJ Neuroscience; 2006; 137(1):133-44. PubMed ID: 16297565 [TBL] [Abstract][Full Text] [Related]
8. Involvement of reactive oxygen species in a feed-forward mechanism of Na/K-ATPase-mediated signaling transduction. Yan Y; Shapiro AP; Haller S; Katragadda V; Liu L; Tian J; Basrur V; Malhotra D; Xie ZJ; Abraham NG; Shapiro JI; Liu J J Biol Chem; 2013 Nov; 288(47):34249-34258. PubMed ID: 24121502 [TBL] [Abstract][Full Text] [Related]
9. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells. Burkard C; Verheije MH; Haagmans BL; van Kuppeveld FJ; Rottier PJ; Bosch BJ; de Haan CA J Virol; 2015 Apr; 89(8):4434-48. PubMed ID: 25653449 [TBL] [Abstract][Full Text] [Related]
10. Ouabain interaction with cardiac Na/K-ATPase reveals that the enzyme can act as a pump and as a signal transducer. Xie Z Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):383-90. PubMed ID: 11357899 [TBL] [Abstract][Full Text] [Related]
11. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136 [TBL] [Abstract][Full Text] [Related]
12. Na+/K+ATPase as a signaling molecule during bovine sperm capacitation. Thundathil JC; Anzar M; Buhr MM Biol Reprod; 2006 Sep; 75(3):308-17. PubMed ID: 16687652 [TBL] [Abstract][Full Text] [Related]
13. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway. Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798 [TBL] [Abstract][Full Text] [Related]
14. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs? Chen JQ; Contreras RG; Wang R; Fernandez SV; Shoshani L; Russo IH; Cereijido M; Russo J Breast Cancer Res Treat; 2006 Mar; 96(1):1-15. PubMed ID: 16322895 [TBL] [Abstract][Full Text] [Related]
15. Na+/K+ pump and endothelial cell survival: [Na+]i/[K+]i-independent necrosis triggered by ouabain, and protection against apoptosis mediated by elevation of [Na+]i. Orlov SN; Thorin-Trescases N; Pchejetski D; Taurin S; Farhat N; Tremblay J; Thorin E; Hamet P Pflugers Arch; 2004 Jun; 448(3):335-45. PubMed ID: 15069561 [TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex. Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758 [TBL] [Abstract][Full Text] [Related]
17. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action. Pôças ES; Costa PR; da Silva AJ; Noël F Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741 [TBL] [Abstract][Full Text] [Related]
18. [Na,K-ATPase and cardiac glycosides: new functions of the known protein]. Lopina OD Ross Fiziol Zh Im I M Sechenova; 2005 Feb; 91(2):158-68. PubMed ID: 15835539 [TBL] [Abstract][Full Text] [Related]
19. ACTH-induced hypertension is dependent on the ouabain-binding site of the alpha2-Na+-K+-ATPase subunit. Lorenz JN; Loreaux EL; Dostanic-Larson I; Lasko V; Schnetzer JR; Paul RJ; Lingrel JB Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H273-80. PubMed ID: 18487447 [TBL] [Abstract][Full Text] [Related]
20. On the differences between ouabain and digitalis glycosides. Fuerstenwerth H Am J Ther; 2014; 21(1):35-42. PubMed ID: 21642827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]